Torsemide is a loop diuretic indicated for: the treatment of edema associated with heart failure, renal disease or hepatic disease. the treatment of hypertension, to lower blood pressure. Lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events, primarily strokes and myocardial infarctions. 1.1 Edema Torsemide is indicated for the treatment of edema associated with heart failure, renal disease, or hepatic disease. 1.2 Hypertension Torsemide is indicated for the treatment of hypertension, to lower blood pressure. Lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events, primarily strokes and myocardial infarctions.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Mar 1, 2005 | Original application | Approved |
| Jul 21, 2023 | Supplement 4Labeling · Standard review | Approved | None posted |
| Sep 26, 2012 | Supplement 3Labeling · Standard review | Approved | None posted |
| Mar 1, 2005 | Original application | Approved |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters
